IBERE PHARMACEUTICALS

Ibere Pharmaceuticals (Nasdaq: IBER) is a blank-check company focused on the healthcare and pharmaceutical sector, formed with the objective of completing a business combination with a target in the life sciences industry. The company filed a 10-Q with the SEC on August 12, 2022, reflecting its operational status during the 2022 search period following its IPO. Like many healthcare-focused SPACs of its vintage, IBER targeted opportunities in drug development, biotechnology, or adjacent pharmaceutical services. Sponsor details were disclosed in the company's registration filings on record with the SEC. Visit SpacDesk and sign up for full data, filings, and deal-tracking on IBER and hundreds of other active and historical SPACs.